These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

674 related items for PubMed ID: 3020495

  • 1. Live attenuated varicella vaccine use in immunocompromised children and adults.
    Gershon AA, Steinberg SP, Gelb L.
    Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
    [Abstract] [Full Text] [Related]

  • 2. A multicentre trial of live attenuated varicella vaccine in children with leukaemia in remission.
    Gershon AA, Steinberg S, Gelb L, Galasso G, Borkowsky W, LaRussa P, Ferrara A.
    Postgrad Med J; 1985 Oct; 61 Suppl 4():73-8. PubMed ID: 3014482
    [Abstract] [Full Text] [Related]

  • 3. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
    Hardy I, Gershon AA, Steinberg SP, LaRussa P.
    N Engl J Med; 1991 Nov 28; 325(22):1545-50. PubMed ID: 1658650
    [Abstract] [Full Text] [Related]

  • 4. [Varicella vaccination].
    Heidl M, Scholz H.
    Padiatr Grenzgeb; 1990 Nov 28; 29(1):31-6. PubMed ID: 2160635
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of varicella vaccine in childhood leukemia. Observation over 6 years.
    Oka T, Iseki K, Oka R, Sakuma S, Yoshioka H, Takahashi M.
    Biken J; 1984 Sep 28; 27(2-3):103-9. PubMed ID: 6100045
    [Abstract] [Full Text] [Related]

  • 6. Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.
    Diaz PS, Au D, Smith S, Amylon M, Link M, Smith S, Arvin AM.
    Pediatrics; 1991 Feb 28; 87(2):166-70. PubMed ID: 1846236
    [Abstract] [Full Text] [Related]

  • 7. Live attenuated varicella vaccine in children with leukemia in remission.
    Gershon AA, Steinberg S, Galasso G, Borkowsky W, Larussa P, Ferrara A, Gelb L.
    Biken J; 1984 Sep 28; 27(2-3):77-81. PubMed ID: 6100063
    [Abstract] [Full Text] [Related]

  • 8. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine.
    Gershon AA, Steinberg SP.
    N Engl J Med; 1989 Apr 06; 320(14):892-7. PubMed ID: 2538749
    [Abstract] [Full Text] [Related]

  • 9. Varicella vaccine studies in healthy children and adults.
    Arbeter AM, Starr SE, Plotkin SA.
    Pediatrics; 1986 Oct 06; 78(4 Pt 2):748-56. PubMed ID: 3020494
    [Abstract] [Full Text] [Related]

  • 10. Study of tolerance and effectiveness of a varicella vaccine in leukemic children.
    Bancillon A, Leblanc T, Baruchel A, Schaison G, Leverger G, Mallarmey D, Teuliere L.
    Nouv Rev Fr Hematol (1978); 1991 Oct 06; 33(6):555-6. PubMed ID: 1667953
    [Abstract] [Full Text] [Related]

  • 11. Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia.
    Brunell PA, Geiser CF, Novelli V, Lipton S, Narkewicz S.
    Pediatrics; 1987 Jun 06; 79(6):922-7. PubMed ID: 3035478
    [Abstract] [Full Text] [Related]

  • 12. The risk of zoster after varicella vaccination in children with leukemia.
    Lawrence R, Gershon AA, Holzman R, Steinberg SP.
    N Engl J Med; 1988 Mar 03; 318(9):543-8. PubMed ID: 2828948
    [Abstract] [Full Text] [Related]

  • 13. Prospects for use of a varicella vaccine in adults.
    Hardy IR, Gershon AA.
    Infect Dis Clin North Am; 1990 Mar 03; 4(1):159-73. PubMed ID: 2155261
    [Abstract] [Full Text] [Related]

  • 14. Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox.
    Brunell PA, Taylor-Wiedeman J, Geiser CF, Frierson L, Lydick E.
    Pediatrics; 1986 Jan 03; 77(1):53-6. PubMed ID: 3455669
    [Abstract] [Full Text] [Related]

  • 15. Vaccination of children with malignant disease against varicella.
    Slørdahl SH, Wiger D, Strømøy T, Degre M, Thørsby E, Lie SO.
    Postgrad Med J; 1985 Jan 03; 61 Suppl 4():85-92. PubMed ID: 3014484
    [Abstract] [Full Text] [Related]

  • 16. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K, Saiman L, LaRussa P, Steinberg S, Annunziato P, Gershon A.
    Clin Infect Dis; 2002 Mar 15; 34(6):774-9. PubMed ID: 11830801
    [Abstract] [Full Text] [Related]

  • 17. Live varicella vaccine in healthy individuals.
    Just M, Berger R, Luescher D.
    Postgrad Med J; 1985 Mar 15; 61 Suppl 4():129-32. PubMed ID: 3014469
    [Abstract] [Full Text] [Related]

  • 18. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
    Prescrire Int; 2005 Jun 15; 14(77):85-91. PubMed ID: 15977369
    [Abstract] [Full Text] [Related]

  • 19. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
    Johnson CE, Shurin PA, Fattlar D, Rome LP, Kumar ML.
    Pediatrics; 1988 Apr 15; 81(4):512-8. PubMed ID: 2832819
    [Abstract] [Full Text] [Related]

  • 20. Varicella-zoster virus. Prospects for active immunization.
    Gershon AA.
    Am J Clin Pathol; 1978 Jul 15; 70(1 Suppl):170-4. PubMed ID: 210654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.